These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 22110695)
21. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635 [TBL] [Abstract][Full Text] [Related]
22. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia. Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093 [TBL] [Abstract][Full Text] [Related]
23. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany. Remschmidt C; Rieck T; Bödeker B; Wichmann O BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ; Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792 [TBL] [Abstract][Full Text] [Related]
25. I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? Kissling E; Nunes B; Robertson C; Valenciano M; Reuss A; Larrauri A; Cohen JM; Oroszi B; Rizzo C; Machado A; Pitigoi D; Domegan L; Paradowska-Stankiewicz I; Buchholz U; Gherasim A; Daviaud I; Horváth JK; Bella A; Lupulescu E; O Donnell J; Korczyńska M; Moren A; Euro Surveill; 2016 Apr; 21(16):. PubMed ID: 27124420 [TBL] [Abstract][Full Text] [Related]
27. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008. Fielding JE; Grant KA; Papadakis G; Kelly HA BMC Infect Dis; 2011 Jun; 11():170. PubMed ID: 21669006 [TBL] [Abstract][Full Text] [Related]
28. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166 [TBL] [Abstract][Full Text] [Related]
29. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. Pelat C; Falchi A; Carrat F; Mosnier A; Bonmarin I; Turbelin C; Vaux S; van der Werf S; Cohen JM; Lina B; Blanchon T; Hanslik T PLoS One; 2011 May; 6(5):e19621. PubMed ID: 21573005 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Turner N; Pierse N; Bissielo A; Huang Q; Radke S; Baker M; Widdowson M; Kelly H; Euro Surveill; 2014 Aug; 19(34):. PubMed ID: 25188614 [TBL] [Abstract][Full Text] [Related]
31. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779 [TBL] [Abstract][Full Text] [Related]
32. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020. Dawood FS; Chung JR; Kim SS; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Dunnigan K; Foust A; Sessions W; DaSilva J; Le S; Stark T; Kondor RJ; Barnes JR; Wentworth DE; Brammer L; Fry AM; Patel MM; Flannery B MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(7):177-182. PubMed ID: 32078591 [TBL] [Abstract][Full Text] [Related]
33. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. Savulescu C; Jiménez-Jorge S; de Mateo S; Pozo F; Casas I; Breña PP; Galmés A; Vanrell JM; Rodriguez C; Vega T; Martinez A; Torner N; Ramos JM; Serrano MC; Castilla J; Cenoz MG; Altzibar JM; Arteagoitia JM; Quiñones C; Perucha M; Larrauri A BMC Public Health; 2011 Nov; 11():899. PubMed ID: 22129083 [TBL] [Abstract][Full Text] [Related]
34. Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus. Kurečić Filipović S; Gjenero-Margan I; Kissling E; Kaić B; Cvitković A Epidemiol Infect; 2015 Sep; 143(12):2596-603. PubMed ID: 25567212 [TBL] [Abstract][Full Text] [Related]
35. Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. Flannery B; Smith C; Garten RJ; Levine MZ; Chung JR; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman R; Nowalk MP; Griffin MR; Keipp Talbot H; Treanor JJ; Wentworth DE; Fry AM J Infect Dis; 2018 Jun; 218(2):189-196. PubMed ID: 29361005 [TBL] [Abstract][Full Text] [Related]
36. Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study. Maurel M; Pozo F; Pérez-Gimeno G; Buda S; Sève N; Oroszi B; Hooiveld M; Gomez V; Domegan L; Martínez-Baz I; Ilić M; Carnahan AS; Mihai ME; Martínez A; Goerlitz L; Enouf V; Horváth JK; Dijkstra F; Rodrigues AP; Bennett C; Trobajo-Sanmartín C; Mlinarić I; Latorre-Margalef N; Ivanciuc A; Lopez A; Dürrwald R; Falchi A; Túri G; Meijer A; Melo A; O'Donnell J; Castilla J; Vučina VV; Hagey TS; Lazar M; Kaczmarek M; Bacci S; Kissling E; Influenza Other Respir Viruses; 2024 Jan; 18(1):e13243. PubMed ID: 38204584 [TBL] [Abstract][Full Text] [Related]
37. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016. Balasubramani GK; Nowalk MP; Sax TM; Suyama J; Bobyock E; Rinaldo CR; Martin ET; Monto AS; Jackson ML; Gaglani MJ; Flannery B; Chung JR; Zimmerman RK Influenza Other Respir Viruses; 2020 Jul; 14(4):380-390. PubMed ID: 32298048 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study. Kafatos G; Pebody R; Andrews N; Durnall H; Barley M; Fleming D Influenza Other Respir Viruses; 2013 Nov; 7(6):1175-80. PubMed ID: 24103037 [TBL] [Abstract][Full Text] [Related]
40. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]